[Current Data] Rule running report - 2024-08-31 18:48:01.389851

Nr2LONDON/NEW YORK (Reuters) – As Eli Lilly's weight-loss drug Zepbound gains ground in the U.S. against Novo Nordisk's Wegovy, some doctors say their guiding principle for writing prescriptions is simple:… succesfully run! 0 Anläufe!